Magtrace and Sentimag Magnetic Localization System
FDA premarket approval P160053/S009 · decided 2024-04-15
Approval details
- PMA number
- P160053
- Supplement
- S009
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Magtrace and Sentimag Magnetic Localization System
- Generic name
- Lymph node location system during sentinel biopsy procedure
- Applicant
- Endomagnetics Ltd.,
- Date received
- 2023-06-12
- Decision date
- 2024-04-15
- Days to decision
- 308 days
- Decision code
- APPR
- Product code
- PUV
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Cambridge
- Statement
- using a new dose (1 ml) of Magtrace with Sentimag® Magnetic Localization System to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy or lumpectomy
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Magseed Pro Magnetic Marker System (K232865) | Endomagnetics Ltd., | 2024-06-28 |
| Sentimag System (K222832) | Endomagnetics Ltd., | 2023-01-21 |
| Magseed Magnetic Marker Systtem (K173587) | Endomagnetics Ltd., | 2018-02-16 |
| Magseed Magnetic Marker System (K163541) | Endomagnetics Ltd., | 2017-01-13 |
| Sentimag System, Sentimark Magnetic Marker Systerm (K153044) | Endomagnetics Ltd., | 2016-03-02 |